Welcome to the Illinois Medical Oncology Society

IMOS is dedicated to ensuring you stay informed during the COVID-19 crisis. Click above to find all of the latest resources from ASCO, ASH, COA, HOSS, and important Industry News related to the crisis.

Illinois Department of Public Health COVID-19 Resources, Click here for more.


BREAKING NEWS: National healthcare organizations urge Governors and Insurance Commissioners throughout the country to support broad coverage and payment of telemedicine services even after the COVID-19 pandemic ends. Read the letters to the Governors and the Insurance Commissioners here.


Formed on July 29, 1989, the Illinois Medical Oncology Society (IMOS) represents the common interests of a majority of the oncologists treating cancer in Illinois. As the oncology society in Illinois, we strive to provide our members with innovative resources to help them stay ahead of the shifting healthcare landscape and challenges that directly impact the high-quality care their patients deserve.

The Illinois Medical Oncology Society now offers FREE  memberships to oncologists and allied oncology professionals.

Find out more about membership

The IMOS board would also like to hear from you (all levels and types of members and potential members) about things you’d like to see for 2019 - 2020 and how we can best serve your needs.

We are a State Affiliate of the American Society of Clinical Oncology.

Our Mission

We strive to promote the highest professional standards of oncology in the State of Illinois.  We create educational experiences for our members to exchange information to increase the quality of care for our patients. We act as a patient advocate to assure that patients have access to the best available care; and support and encourage clinical research against cancer.

Find out more

 

IMOS MEMBERS ENCOURAGED TO REGISTER FOR ACS CAN ILLINOIS POLICY FORUM, SEPTEMBER 23
The ACS Cancer Facts and Figures reports shows since 1991 there has been a 30% drop in cancer mortality and a major factor in that has been the rise of immunotherapies. Immunotherapies are revolutionizing cancer care and the patient experience. The conversation will center around the intersection of healthcare, policy, and the patient experience.  IMOS Board Member Sunandana Chandra, MD, will be participating in the panel discussion. The forum will be held Wednesday, September 23rd, 2020, from 12 to 1pm.

Find out more

 IMOS SUPPORTS SENATE BILL 2499
IMOS joined with ASCO recently in support of Senate Bill 2499, which would guarantee coverage of the routine care costs for clinical trials participation for Medicaid enrollees in Illinois.  Read the joint letter sent to the bill sponsor, Senator Andy Lamar, here.


CORONAVIRUS INFORMATION FROM THE CDC

CDC is working across the Department of Health and Human Services and across the U.S. government in the public health response to COVID-19.
Please see links below for additional information:


IMPORTANT INFORMATION FOR ALL PROVIDERS
FROM THE AMERICAN MEDICAL ASSOCIATION

As of January 1, 2021, there will be significant changes to the office and outpatient Evaluation and Management (E&M) services (CPT ® codes 99202-99215) for both new and established patients.

Find out more

ONLINE RESOURCES

Academy Managed Care Pharmacists Webinar on the use of BeiGene’s FDA-Approved BTK Inhibitor for the treatment of Mantle Cell Lymphoma, sponsored by BeiGene. Click HERE for more information and to view the webinar.


RxVantage recently shared a panel discussion of oncology experts from around the country who have exhibited impressive leadership amid COVID-19. These executives met via video conference to share experiences, discuss strategies that have worked (as well as those that have not), and their plans for moving forward. Click below to view each presentation:

 

 

News

IMOS congratulates the four Illinois practices receiving QOPI certification in the fourth quarter of 2019:


    Advocate Infusion Center – Darien – Darien, IL
    Advocate Medical Group – Chicago, IL
    Creticos Cancer Center – Chicago, IL
    Illinois Cancer Specialists – Schaumburg, IL

Find out more

Current news

  • September 18, 2020 - CMS Finalizes Radiation Oncology Model - Find out more
  • September 16, 2020 - AACR Releases Its Inaugural Cancer Disparities Report - Find out more
  • September 1, 2020 - CMS Quietly Resumes Practice Audits, Find out more
  • August 14, 2020 - One of the nation’s leading cancer organizations today called for new actions to reduce disparities in cancer outcomes affecting racial and ethnic minorities, rural populations, sexual and gender minorities, people without insurance, and other disadvantaged populations. In a policy statement published in the Journal of Clinical Oncology (JCO), the American Society of Clinical Oncology (ASCO) argues that while progress has been made in raising awareness of disparities and driving research, the cancer community needs to take bolder, more aggressive steps to achieve equity for all patients. More information.

IMOS is happy to have partnered with NCODA to present their most recent webinars. You can watch all five parts of the COVID-19 series and a special ASCO/NCODA webinar on Patient-Centered Standards for Medically Integrated Dispensing by clicking HERE.